Literature DB >> 10866899

Nitrous oxide prevents movement during orotracheal intubation without affecting BIS value.

C Coste1, B Guignard, C Menigaux, M Chauvin.   

Abstract

UNLABELLED: We sought to determine whether the addition of nitrous oxide (N(2)O) to an anesthetic with propofol and remifentanil modifies the bispectral index (BIS) during the induction of anesthesia and orotracheal intubation. Thirty ASA physical status I or II patients were randomly allocated to receive either 50% air in oxygen (control group) or 60%-70% N(2)O in oxygen (N(2)O group) that was commenced via a mask simultaneously with the induction of anesthesia. Anesthesia was performed in all the patients with IV propofol at the target effect compartment site concentration of 4 microg/mL throughout the study. A target-controlled infusion (TCI) of remifentanil was initiated 3 min after the TCI of propofol and maintained at the effect-site concentration of 4 ng/mL until the end of the study. After loss of consciousness, and before the administration of vecuronium 0.1 mg/kg, a tourniquet was applied to one arm and inflated to a value more than the systolic blood pressure. An examiner, blinded to the presence of N(2)O, sought to detect any gross movement within the first minute after tracheal intubation, which was performed 10 min after remifentanil TCI began. Inspired and expired oxygen, N(2)O, and carbon dioxide were continuously monitored. A BIS value was generated every 10 s. Arterial blood pressure and heart rate (HR) were measured noninvasively every minute. Measures of mean arterial pressure (MAP), HR, and BIS were obtained before the induction, before the start of the remifentanil TCI, before laryngoscopy, and 5 min after intubation. No significant intergroup differences were seen in BIS, HR, and MAP throughout the study. Maximum changes in BIS, HR, and MAP with intubation were significant (P < 0.01) for both groups but comparable. Six patients in the control group and none in the N(2)O group moved after intubation (P < 0.05). IMPLICATIONS: We demonstrated that 0.6 minimal alveolar concentration of nitrous oxide combined with a potent anesthetic and an opioid prevents movement after orotracheal intubation without affecting the bispectral index. This demonstrates that the bispectral index is not a useful neurophysiologic variable to monitor the level of anesthesia when nitrous oxide is added to a general anesthetic regimen using propofol and remifentanil.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866899     DOI: 10.1097/00000539-200007000-00024

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

Review 1.  Induction of anaesthesia: a guide to drug choice.

Authors:  Nathalie Nathan; Isabelle Odin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  [Depth of anaesthesia during intubation: comparison between propofol and thiopentone].

Authors:  C E Beck; B Pohl; M Janda; J Bajorat; R Hofmockel
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

3.  The effect of atropine on the bispectral index response to endotracheal intubation during propofol and remifentanil anesthesia.

Authors:  Hyun Jeong Kwak; Bong Ki Moon; Chang Keun Oh; Young Jin Chang; Hong Soon Kim; Jong Yeop Kim
Journal:  J Clin Monit Comput       Date:  2012-10-30       Impact factor: 2.502

4.  Bispectral index response to cricoid pressure during induction of general anesthesia.

Authors:  Saeed Abbasi; Reihanak Talakoub; Babak Jahangirifard; Mehrdad Masoodifar; Hamid Saryazdi
Journal:  J Res Med Sci       Date:  2011-01       Impact factor: 1.852

5.  Interactions of propofol and remifentanil on bispectral index under 66% N(2)O: analysis by dose-effect curve, isobologram, and combination index.

Authors:  Won Ho Kim; Hyun Joo Ahn; Jie Ae Kim
Journal:  Korean J Anesthesiol       Date:  2010-12-31

6.  Clinical vs. bispectral index-guided propofol induction of anesthesia: A comparative study.

Authors:  Snehdeep Arya; Veena Asthana; Jagdish P Sharma
Journal:  Saudi J Anaesth       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.